Get the Stockscreener App
5.93
9.81%
0.53
After Hours:
5.90
-0.03
-0.51%
Ispecimen Inc stock is traded at $5.93, with a volume of 596.41K.
It is up +9.81% in the last 24 hours and up +4.25% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$5.40
Open:
$5.3
24h Volume:
596.41K
Relative Volume:
0.73
Market Cap:
$4.40M
Revenue:
$1.93M
Net Income/Loss:
$-10.49M
P/E Ratio:
-0.0674
EPS:
-87.9728
Net Cash Flow:
$-5.24M
1W Performance:
+30.04%
1M Performance:
+4.25%
6M Performance:
-78.00%
1Y Performance:
-87.85%
1-Day Range:
$5.30
$6.238
1-Week Range:
$4.00
$6.7699
52-Week Range:
$4.00
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
5.93 | 4.00M | 1.93M | -10.49M | -5.24M | -87.97 |
TMO
Thermo Fisher Scientific Inc
|
466.76 | 171.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.63 | 123.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.97 | 44.73B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
342.75 | 29.63B | 3.17B | 642.63M | 516.49M | 10.77 |
A
Agilent Technologies Inc
|
117.53 | 31.70B | 7.07B | 1.29B | 993.00M | 4.5355 |
Ispecimen Inc Stock (ISPC) Latest News
MSN Money - MSN
iSpecimen Inc (ISPC) - MSN
ISPC Jumps As iSpecimen Inc. Draws Trader Attention - StocksToTrade
ISPC Extends Volatile Rally As Traders Gauge Deep Losses - timothysykes.com
iSpecimen Completes 1-for-40 Reverse Stock Split - The Globe and Mail
iSpecimen (ISPC) Announces 1-for-40 Reverse Stock Split Effective April 27, 2026 to Maintain Nasdaq Listing - Minichart
ISPC Stock Surges After Volatile Breakout Move - timothysykes.com
iSpecimen (ISPC) trims share count with 1-for-40 reverse split - Stock Titan
ISPC Stock Jumps After Volatile Low-Float Breakout - timothysykes.com
ISPC Jumps As Traders Target High-Volatility Spike - timothysykes.com
Why iSpecimen Stock Whipsawed After Its 1-for-40 Reverse Split - TechStock²
ISPC Stock Explodes Higher As Traders Target Low-Float Runner - StocksToTrade
ISPC Stock Explodes Higher As Traders Pile Into Micro-Float Runner - timothysykes.com
Top pre-market gainers today — ISPC, WGRX, RAYA among stocks that are soaring before the bell - MSN
Why iSpecimen Shares Are Surging On Friday? - MSN
iSpecimen is trending overnight — here's why ISPC stock surged 56% in the after-hours session - MSN
ISpecimen Announces 1-for-40 Reverse Stock Split - marketscreener.com
iSpecimen announces 1-for-40 reverse stock split effective Monday By Investing.com - Investing.com Australia
ISPC iSpecimen shares drop 19.6% after massive Q3 2024 EPS miss far trails analyst expectations.Verified Stock Signals - Newser
iSpecimen announces 1-for-40 reverse stock split effective Monday - Investing.com
iSpecimen Announces 1-for-40 Reverse Stock Split - The Globe and Mail
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):